Manas Resources EBITDA margin
¿Qué es el EBITDA margin de Manas Resources?
El EBITDA margin de Manas Resources Limited es -1,983.95%
¿Cuál es la definición de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de compañías en Sector Materials en ASX en comparadas con Manas Resources
¿Qué hace Manas Resources?
Manas Resources Limited engages in the acquisition, exploration, evaluation, and development of gold properties in Australia. Its principal properties include the Mbengué project that covers an area of approximately 400 square kilometers; Eburnea project; and Gonsan project comprising 3 exploration permit applications covering a combined area of approximately 1,000 square kilometers located in Côte D'Ivoire. Manas Resources Limited was incorporated in 2007 and is based in Mount Hawthorn, Australia.
Empresas con ebitda margin similar a Manas Resources
- AFC plc tiene EBITDA margin de -2,006.21%
- AFC plc tiene EBITDA margin de -2,006.21%
- Shree Minerals tiene EBITDA margin de -1,996.58%
- Mirati Therapeutics Inc tiene EBITDA margin de -1,991.78%
- Nanoveu tiene EBITDA margin de -1,986.23%
- Helius Medical Technologies Inc tiene EBITDA margin de -1,984.85%
- Manas Resources tiene EBITDA margin de -1,983.95%
- Fourth Wave tiene EBITDA margin de -1,972.64%
- Skychain Technologies tiene EBITDA margin de -1,970.98%
- DBV Technologies tiene EBITDA margin de -1,960.96%
- Sultan Resources tiene EBITDA margin de -1,947.34%
- Kronos Bio tiene EBITDA margin de -1,945.08%
- Havn Life Sciences Inc tiene EBITDA margin de -1,929.90%